Cadrenal Therapeutics

Ponte Vedra Beach, United States

Cadrenal Therapeutics develops a late-stage novel therapy for patients with end-stage renal disease and atrial fibrillation.

$2.5M raised

Apr 2026

Post-IPO Equity

Biopharma Health Care Medical Therapeutics

Founder Contacts

30,000+ verified contacts

Get Instant Access

Emails, phones & LinkedIn profiles

Frequently Asked Questions about Cadrenal Therapeutics

How much funding has Cadrenal Therapeutics raised?

Cadrenal Therapeutics has raised $2.5M in total funding. The most recent round was Post-IPO Equity. The last funding was announced in April 2026.

Where is Cadrenal Therapeutics headquartered?

Cadrenal Therapeutics is headquartered in Ponte Vedra Beach, United States.

What does Cadrenal Therapeutics do?

Cadrenal Therapeutics develops a late-stage novel therapy for patients with end-stage renal disease and atrial fibrillation.

What stage is Cadrenal Therapeutics at?

Cadrenal Therapeutics is at the Post-IPO Equity stage.

Cite this page

Free to use in articles, research, and reference works. Stable URL — will not change. Data on this page last updated April 1, 2026.

MLA

"Cadrenal Therapeutics — Funding & Investors." VCBacked, April 1, 2026, https://www.vcbacked.co/company/cadrenal-therapeutics. Accessed July 2, 2026.

APA

VCBacked. (2026). Cadrenal Therapeutics — Funding & Investors. Retrieved July 2, 2026, from https://www.vcbacked.co/company/cadrenal-therapeutics

Wikipedia (cite web)

{{cite web |title=Cadrenal Therapeutics — Funding & Investors |url=https://www.vcbacked.co/company/cadrenal-therapeutics |website=VCBacked |access-date=July 2, 2026}}

Profile data sourced and verified per the VCBacked methodology. Last funding round dated April 1, 2026.

Similar Companies in Biopharma

View all

Allterum Therapeutics

Living In Silico Inc.